Scholarlink

Main conclusion <p>The combination of bioinformatics and functional approaches was used to identify three cytochrome P450 from the CYP71 clan that perform the 19-hydroxylation of two monoterpene indole alkaloids (coronaridine and voacangine) from <i>Voacanga thouarsii</i>.&#xa0;</p> Abstract <p><i>Voacanga thouarsii</i> is a medicinal plant from the Apocynaceae family producing monoterpene indole alkaloids (MIAs), notably iboga-type ones, to cope with their environment. Iboga MIAs, including ibogaine or voacristine, display a wide range of pharmacological properties explaining the ever-growing interest in these compounds. Although much of the iboga biosynthetic pathway has been resolved, the enzymes responsible for the C19-hydroxylation of coronaridine and voacangine, which leads to heyneanine and voacristine, remain unknown. Using newly available genomic and transcriptomic resources, we performed an orthology-guided strategy to identify candidate cytochrome P450 enzymes from the CYP71 family. Functional characterization through transient expression in <i>Nicotiana benthamiana</i> revealed three closely related enzymes capable of stereospecific C19-hydroxylation of both substrates. These enzymes, named voacangine/coronaridine hydroxylases (VCOH1–3), display moderate substrate specificity and a preferential activity toward coronaridine. Subcellular localization confirmed their association with the endoplasmic reticulum, consistent with other MIA-related P450s. Homology modeling and molecular docking analyses identified key residues that constrain substrate orientation and explain the observed stereochemical outcome of hydroxylation. Together, these findings complete the biosynthetic pathways of voacristine and heyneanine and highlight convergent evolutionary solutions for C19-hydroxylation within MIAs. By identifying and mechanistically characterizing the enzymes responsible for this missing biosynthetic step, this work significantly advances the state of the art in iboga MIA biosynthesis and provides new molecular tools for their metabolic engineering and the sustainable production of these valuable compounds. </p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Voacangine/coronaridine hydroxylases catalyze C19-hydroxylation in iboga alkaloid synthesis

  • 期刊论文

  • 发表日期：

    2026年3月23日

查看全文
  • Ana Luisa Lopez-Vazquez,
  • Mickael Durand,
  • Caroline Birer-Williams,
  • Elfie Perdereau,
  • Emeline Marais,
  • Thomas Perrot,
  • Audrey Oudin,
  • Arnaud Lanoue,
  • Benoit St-Pierre,
  • Nicolas Papon,
  • Georges Massiot,
  • Chao Sun,
  • Sébastien Besseau,
  • Vincent Courdavault

摘要

Main conclusion

The combination of bioinformatics and functional approaches was used to identify three cytochrome P450 from the CYP71 clan that perform the 19-hydroxylation of two monoterpene indole alkaloids (coronaridine and voacangine) from Voacanga thouarsii. 

Abstract

Voacanga thouarsii is a medicinal plant from the Apocynaceae family producing monoterpene indole alkaloids (MIAs), notably iboga-type ones, to cope with their environment. Iboga MIAs, including ibogaine or voacristine, display a wide range of pharmacological properties explaining the ever-growing interest in these compounds. Although much of the iboga biosynthetic pathway has been resolved, the enzymes responsible for the C19-hydroxylation of coronaridine and voacangine, which leads to heyneanine and voacristine, remain unknown. Using newly available genomic and transcriptomic resources, we performed an orthology-guided strategy to identify candidate cytochrome P450 enzymes from the CYP71 family. Functional characterization through transient expression in Nicotiana benthamiana revealed three closely related enzymes capable of stereospecific C19-hydroxylation of both substrates. These enzymes, named voacangine/coronaridine hydroxylases (VCOH1–3), display moderate substrate specificity and a preferential activity toward coronaridine. Subcellular localization confirmed their association with the endoplasmic reticulum, consistent with other MIA-related P450s. Homology modeling and molecular docking analyses identified key residues that constrain substrate orientation and explain the observed stereochemical outcome of hydroxylation. Together, these findings complete the biosynthetic pathways of voacristine and heyneanine and highlight convergent evolutionary solutions for C19-hydroxylation within MIAs. By identifying and mechanistically characterizing the enzymes responsible for this missing biosynthetic step, this work significantly advances the state of the art in iboga MIA biosynthesis and provides new molecular tools for their metabolic engineering and the sustainable production of these valuable compounds.